Import Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M from South Korea
Import trade data for Indian businesses
🇰🇷 South Korea — Country Profile
Capital
Seoul
GDP (USD)
$2K
Population
51.7M
Currency
Won
Trade Agreement
APTA, India-Korea CEPA
Import Snapshot
India imported $24.2M of antisera and other blood fractions and modified immunological products, whether or not obtained by m from South Korea in 2024 — +110.1% YoY.
Based on HS Code 3002 import data (UN Comtrade)
Import History — South Korea to India
2024
$24.2M
HS 3002 imports
2023
$11.5M
HS 3002 imports
2022
$25.2M
HS 3002 imports
About Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M Imports from South Korea
South Korea is one of the supplying countries for antisera and other blood fractions and modified immunological products, whether or not obtained by m to the Indian market, classified under HS heading 3002. Indian importers source this product for domestic consumption, manufacturing inputs, or re-export.
Other Countries Supplying Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M to India
Import Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M from South Korea
Get expert guidance on sourcing, customs procedures, and compliance.
Contact XIMPEX